ASCO 2019 day five

ASCO 2019 Live coverage
ASCO-2019-Feature-Banner-840x480-NEW

Exclusive live coverage from day five of the American Society of Clinical Oncology's annual meeting in Chicago. • To view all of our coverage from the preeminent cancer event, produced in association with Kantar Health, as well as additional content, visit the Spotlight on ASCO 2019 and the future of oncology On the agenda for Tuesday:

  • An oral presentation will discuss results of a phase 2 trial of Ipsen/Exelixis’ cabozantinib vs. chemotherapy, based on data from the phase 2 Alliance A091201 study in metastatic and primary uveal melanoma.

  View the live coverage from day five at ASCO 2019 below (the live blog may take a few seconds to load):

 


Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

R&D
EHS&S for Biopharma & Pharma Summit banner
Partner Content

EHS&S for Biopharma & Pharma Summit

Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities

R&D
Proteomic Based Drug Discovery Summit 2025 banner
Partner Content

Proteomic Based Drug Discovery Summit 2025

Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T